ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,054,537 | -19.5% | 193,493 | -0.9% | 0.00% | 0.0% |
| Q2 2023 | $1,309,711 | -26.3% | 195,188 | -3.0% | 0.00% | -33.3% |
| Q1 2023 | $1,777,620 | +10.9% | 201,316 | -4.1% | 0.00% | 0.0% |
| Q4 2022 | $1,603,147 | +7.3% | 209,836 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,494,000 | -13.6% | 209,954 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,730,000 | +15.5% | 213,782 | +589.3% | 0.00% | 0.0% |
| Q2 2019 | $1,498,000 | – | 31,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |